Anteo Diagnostics Ltd. | Income Statement
Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
309.80
465.20
724.50
410.60
236.40
Cost of Goods Sold (COGS) incl. D&A
104.50
162.30
-
-
-
Gross Income
205.20
302.90
-
-
-
SG&A Expense
5,023.40
6,502.60
8,856.80
4,372.90
3,809.60
EBIT
4,818.20
-
-
4,150.20
3,573.10
Unusual Expense
-
-
-
3,599.00
-
Non Operating Income/Expense
949.30
865.30
233.90
59.30
18.90
Interest Expense
-
0.00
519.70
1,383.70
566.30
Pretax Income
3,695.80
5,308.10
8,616.30
9,067.30
4,104.50
Income Tax
1,203.70
1,087.40
1,545.40
2,061.20
744.90
Consolidated Net Income
2,492.20
4,220.80
7,070.90
7,006.20
3,359.60
Net Income
2,492.20
4,220.80
7,070.90
7,006.20
3,359.60
Net Income After Extraordinaries
2,492.20
4,220.80
8,046.10
3,484.10
3,109.40
Net Income Available to Common
2,492.20
4,220.80
6,095.80
10,528.30
3,609.90
EPS (Basic)
0.00
0.00
0.00
0.01
0.00
Basic Shares Outstanding
806,102.60
848,659.00
948,550.00
1,122,300.10
1,149,506.00
EPS (Diluted)
0.00
0.00
0.01
0.01
0.00
Diluted Shares Outstanding
864,529.80
848,659.00
948,550.00
1,122,300.10
1,149,506.00
EBITDA
4,713.60
6,037.40
8,132.40
3,962.30
-
Non-Operating Interest Income
173.10
134.10
29.30
6.30
18.90
About Anteo Diagnostics
View Profile
